Publications by authors named "Oliver Neels"

Claim this Profile
R
Radiolabeled PSMA Inhibitors.
Oliver C Neels, Klaus Kopka, Christos Liolios, Ali Afshar-Oromieh

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
Francisco Alves, Inês F Antunes, Emiliano Cazzola, Frederik Cleeren, Bart Cornelissen, Oliver C Neels

EJNMMI Radiopharm Chem· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging Radionuclides in a Regulatory Framework for Medicinal Products - How Do They Fit?
Clemens Decristoforo, Oliver Neels, Marianne Patt

Front Med (Lausanne)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals.
Nic Gillings, Olaug Hjelstuen, Jim Ballinger, Martin Behe, Clemens Decristoforo, Oliver Neels

EJNMMI Radiopharm Chem· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated [F]PSMA-1007 production by a single use cassette-type synthesizer for clinical examination.
Sadahiro Naka, Tadashi Watabe, Kenta Kurimoto, Motohide Uemura, Fumihiko Soeda, Oliver C Neels

EJNMMI Radiopharm Chem· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of F-PSMA-1007 Uptake in Prostate Cancer Using Different Peptide Concentrations: Preclinical PET/CT Study on Mice.
Fumihiko Soeda, Tadashi Watabe, Sadahiro Naka, Yuwei Liu, Genki Horitsugi, Oliver C Neels

J Nucl Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA damage in human whole blood caused by radiopharmaceuticals evaluated by the comet assay.
Heinz H Schmeiser, Karl-Rudolf Muehlbauer, Walter Mier, Ann-Christin Baranski, Oliver Neels

Mutagenesis· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radionuclides: medicinal products or rather starting materials?
Oliver Neels, Marianne Patt, Clemens Decristoforo

EJNMMI Radiopharm Chem· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection Efficacy of F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy.
Frederik L Giesel, Karina Knorr, Fabian Spohn, Leon Will, Tobias Maurer, Oliver Neels

J Nucl Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Initiation of clinical multicentre studies with local radiotracer production - Regulatory environment and radiopharmaceutical-organisational aspects].
Claus Zippel, Oliver C Neels, Ute Hennrich, Frederik L Giesel, Klaus Kopka

Nuklearmedizin· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraindividual Comparison of F-PSMA-1007 and F-DCFPyL PET/CT in the Prospective Evaluation of Patients with Newly Diagnosed Prostate Carcinoma: A Pilot Study.
Frederik L Giesel, Leon Will, Ismaheel Lawal, Thabo Lengana, Clemens Kratochwil, Oliver Neels

J Nucl Med· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tracer uptake in mediastinal and paraaortal thoracic lymph nodes as a potential pitfall in image interpretation of PSMA ligand PET/CT.
Ali Afshar-Oromieh, Lars Peter Sattler, Katja Steiger, Tim Holland-Letz, Marcelo Livorsi da Cunha, Oliver Neels

Eur J Nucl Med Mol Imaging· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biochemical Recurrence of Prostate Cancer: Initial Results with [F]PSMA-1007 PET/CT.
Frederik L Giesel, Leon Will, Claudia Kesch, Martin Freitag, Christophe Kremer, Oliver C Neels

J Nucl Med· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraindividual Comparison of F-PSMA-1007 PET/CT, Multiparametric MRI, and Radical Prostatectomy Specimens in Patients with Primary Prostate Cancer: A Retrospective, Proof-of-Concept Study.
Claudia Kesch, Maria Vinsensia, Jan P Radtke, Heinz P Schlemmer, Martina Heller, Oliver C Neels

J Nucl Med· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbon ion radiotherapy: impact of tumor differentiation on local control in experimental prostate carcinomas.
Christin Glowa, Peter Peschke, Stephan Brons, Oliver C Neels, Klaus Kopka

Radiat Oncol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Diagnostic performance of Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients.
Ali Afshar-Oromieh, Tim Holland-Letz, Frederik L Giesel, Clemens Kratochwil, Walter Mier, Oliver Neels

Eur J Nucl Med Mol Imaging· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Procedures for the GMP-Compliant Production and Quality Control of [F]PSMA-1007: A Next Generation Radiofluorinated Tracer for the Detection of Prostate Cancer.
Jens Cardinale, René Martin, Yvonne Remde, Martin Schäfer, Antje Hienzsch, Oliver C Neels

Pharmaceuticals (Basel)· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic performance of Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients.
Ali Afshar-Oromieh, Tim Holland-Letz, Frederik L Giesel, Clemens Kratochwil, Walter Mier, Oliver Neels

Eur J Nucl Med Mol Imaging· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Evaluation of F-PSMA-1007, a New Prostate-Specific Membrane Antigen Ligand for Prostate Cancer Imaging.
Jens Cardinale, Martin Schäfer, Martina Benešová, Ulrike Bauder-Wüst, Karin Leotta, Oliver C Neels

J Nucl Med· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(18)F-Labelled PSMA-1007 shows similarity in structure, biodistribution and tumour uptake to the theragnostic compound PSMA-617.
Frederik L Giesel, Jens Cardinale, Martin Schäfer, Oliver Neels, Martina Benešová

Eur J Nucl Med Mol Imaging· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions.
Ali Afshar-Oromieh, Henrik Hetzheim, Clemens Kratochwil, Martina Benesova, Matthias Eder, Oliver C Neels

J Nucl Med· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of epothilone B-induced cell death mechanisms in human epithelial cancer cells -in consideration of combined treatment with ionizing radiation.
Tonja Baumgart, Stephan Kriesen, Oliver Neels, Guido Hildebrandt, Katrin Manda

Cancer Invest· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer.
Matthias Eder, Oliver Neels, Miriam Müller, Ulrike Bauder-Wüst, Yvonne Remde

Pharmaceuticals (Basel)· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical characterization of 18F-D-FPHCys, a new amino acid-based PET tracer.
Delphine Denoyer, Laura Kirby, Kelly Waldeck, Peter Roselt, Oliver C Neels

Eur J Nucl Med Mol Imaging· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours.
Michael S Hofman, Grace Kong, Oliver C Neels, Peter Eu, Emily Hong

J Med Imaging Radiat Oncol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis